NVWM LLC’s Ionis Pharmaceuticals IONS Stock Holding History

NVWM LLC’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$13K	–	369
2019 Q2	$13K	Hold	200	–	–	0.01%	271
2019 Q1	$16K	Hold	200	–	–	0.01%	235
2018 Q4	$11K	Hold	200	–	–	0.01%	248
2018 Q3	$10K	Hold	200	–	–	0.01%	254
2018 Q2	$8K	Hold	200	–	–	0.01%	265
2018 Q1	$8K	Buy	+200	New	+$10.2K	0.01%	270

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NVWM LLC's IONS Position: Q3 2019 in Review

NVWM LLC sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 200 shares — an estimated $13K sold.

NVWM LLC first reported a position in IONS in Q1 2018 and held it in 6 quarters. The position peaked at $16K in Q1 2019. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

NVWM LLC reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
NVWM LLC sold 200 Ionis Pharmaceuticals shares in Q3 2019, an estimated $13K.
NVWM LLC first reported a position in Ionis Pharmaceuticals in Q1 2018 and held it in 6 quarters.
NVWM LLC's Ionis Pharmaceuticals position peaked at $16K in Q1 2019.
369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on NVWM LLC's 13F filing for Q3 2019, filed 29 Oct 2019.